Lynkuet is a medicine for hot flashes and night sweats caused by menopause. It is a capsule taken by mouth at bedtime and does not contain hormones. It works by blocking signals in the brain that switch on the body's heat response.
Every report comes from a Lived member, sent anonymously.
Have you tried Lynkuet (Elinzanetant) for Hot Flashes?
Elinzanetant, sold as Lynkuet, is a prescription capsule for moderate to severe hot flashes and night sweats caused by menopause. Doctors call these vasomotor symptoms: sudden waves of heat, flushing and sweating that can disrupt the day and wake people at night. The US Food and Drug Administration (FDA) approved it in 2025. Elinzanetant contains no estrogen or other hormones. Hormone therapy is still the most effective treatment for hot flashes, but some people should not take it, for example because of an estrogen-sensitive cancer or cardiovascular disease, and others prefer not to. For them, elinzanetant joins other nonhormonal choices, including fezolinetant (Veozah), a closely related medicine, and certain antidepressants or gabapentin. It has also been studied for hot flashes caused by hormone-blocking treatment for breast cancer, but that use is not part of its US approval.
Hot flashes start in the hypothalamus, the part of the brain that acts as the body's thermostat. Estrogen normally keeps a group of nerve cells there in check. As estrogen falls during menopause, a chemical messenger called neurokinin B overstimulates those cells, and the thermostat starts reacting to small changes as if the body were overheating. The result is flushing and sweating meant to shed heat that was never really there. Elinzanetant blocks the receptors for two related messengers, neurokinin B and substance P, which calms the activity behind hot flashes. Fezolinetant blocks only the neurokinin B receptor. Because elinzanetant works on this brain signal rather than replacing estrogen, it treats hot flashes and night sweats, not other effects of lower estrogen.
The usual dose is two 60 mg capsules (120 mg) taken together once a day at bedtime, at about the same time each night, with or without food. Swallow the capsules whole with water; do not cut, crush or chew them. Taking it at bedtime matters because the medicine can cause sleepiness. Before starting, the prescriber checks liver blood tests and makes sure the person is not pregnant. Someone who also takes a medicine that moderately slows its breakdown may be told to take just one capsule a night. If a bedtime dose is missed, skip it and take the next dose the following night; do not take two doses on the same day.
The most common side effects are headache, tiredness, dizziness and sleepiness. Some people also notice heartburn or reflux, nausea, stomach pain, diarrhea, rash or muscle spasms. In the trials, about 12 in 100 people taking elinzanetant had nervous system effects such as sleepiness, fatigue or dizziness, compared with about 4 in 100 on placebo. Sleepiness can carry into the next day. In a driving study, some people's driving was impaired the morning after their first dose. Anyone who feels drowsy, dizzy or foggy during the day should not drive or do risky work until that passes, and should tell the prescriber if it continues. A small number of people became more sensitive to sunlight.
Elinzanetant must not be taken during pregnancy. Animal studies suggest it can cause pregnancy loss or stillbirth. Anyone who could still become pregnant should use effective birth control during treatment and for 2 weeks after stopping, and should stop the medicine and contact the prescriber right away if pregnancy is suspected. Liver enzyme increases occurred in a small number of people. Blood tests are done before starting and again about 3 months in, and the medicine is not recommended for people with moderate or severe liver disease. Stop taking it and contact the care team promptly for signs that could mean liver injury: yellowing of the skin or eyes, dark urine, pale stools, itching, or new tiredness, loss of appetite, nausea, vomiting or stomach pain. Seizures have been reported. Tell the prescriber about any history of seizures or a condition that makes seizures more likely. Elinzanetant is broken down by a liver enzyme called CYP3A4. Medicines that strongly block this enzyme, and grapefruit or grapefruit juice, can raise its levels and should be avoided; moderate blockers call for the lower one-capsule dose. Medicines that speed up the enzyme can make it less effective and should also be avoided. Elinzanetant itself can raise levels of some other drugs handled by the same enzyme. Many prescription and over-the-counter medicines and supplements affect this enzyme, so have the prescriber or pharmacist review everything you take.
Relief can start quickly. In the main trials, hot flashes dropped more than with placebo as early as the first week. People started with roughly 13 to 16 moderate to severe hot flashes a day; after 12 weeks, those taking elinzanetant had about 9 to 10 fewer a day, compared with about 5 to 6 fewer on placebo. Sleep and menopause-related quality of life also improved more than with placebo, and the benefit held for up to about a year in longer studies. Hot flashes usually lessen rather than disappear completely, and response varies from person to person. The main planned follow-up is the liver blood test at about 3 months, along with a check on how well it is working and whether daytime sleepiness is a problem. It has not been studied enough in people over 65 to know whether they respond differently, and it is not for children. How long to continue is a decision to revisit with the prescriber; the longest studies so far ran about a year.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Lynkuet (Elinzanetant), what you've noticed, or ask the community a question.